Viewing Study NCT03338920


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-03-09 @ 12:19 AM
Study NCT ID: NCT03338920
Status: TERMINATED
Last Update Posted: 2023-07-24
First Post: 2017-11-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Sponsor: Currax Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 17-AVP-825-301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators